Advanced

In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT

Geisler, C.; Elonen, E.; Kolstad, A.; Laurell, A.; Sundstrom, C; Delabie, J.; Ehinger, Mats LU ; Karjalainen-Lindsberg, M-L; Ralfkiaer, E. and Brown, P. (2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0971-0971
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haematologica-The Hematology Journal
volume
94
pages
0971 - 0971
publisher
Ferrata Storti Foundation
conference name
14th Annual Meeting of the European-Hematology-Association
external identifiers
  • wos:000266931901059
ISSN
0390-6078
language
English
LU publication?
yes
id
7f0988d5-e5f6-4e87-a54b-eda33879b98e (old id 1462660)
date added to LUP
2009-08-31 10:52:05
date last changed
2016-09-05 14:10:53
@misc{7f0988d5-e5f6-4e87-a54b-eda33879b98e,
  author       = {Geisler, C. and Elonen, E. and Kolstad, A. and Laurell, A. and Sundstrom, C and Delabie, J. and Ehinger, Mats and Karjalainen-Lindsberg, M-L and Ralfkiaer, E. and Brown, P.},
  issn         = {0390-6078},
  language     = {eng},
  note         = {Conference Abstract},
  pages        = {0971--0971},
  publisher    = {Ferrata Storti Foundation},
  series       = {Haematologica-The Hematology Journal},
  title        = {In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT},
  volume       = {94},
  year         = {2009},
}